Concepedia

In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections

Thomas R. Fritsche, Jeffrey T. Kirby, Ronald N. Jones

Diagnostic Microbiology and Infectious Disease · 2004 · 75 citations · 23 references

DOI

Concepts

References

23

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

Mary Jane Ferraro · 2000 · 16.9K citations

, , +10

Bacterial Resistance: Origins, Epidemiology, and Impact

David M. Livermore · Clinical Infectious Diseases · 2003 · 583 citations · Full text

, , +17

In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- <i>t</i> -Butylglycylamido Derivative of Minocycline (GAR-936)

Peter J. Petersen, N V Jacobus, Jason Weiss et al. · Antimicrobial Agents and Chemotherapy · 1999 · 411 citations · Full text

, , +17

Vancomycin-Resistant <i>Staphylococcus aureus</i> Isolate from a Patient in Pennsylvania

Fred C. Tenover, Linda M. Weigel, Peter C. Appelbaum et al. · Antimicrobial Agents and Chemotherapy · 2003 · 372 citations · Full text

, , +16

Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates

Ana Cristina Gales, Ronald N. Jones · Diagnostic Microbiology and Infectious Disease · 2000 · 190 citations

, , +7